The global mammography market size accounted for USD 2.60 billion in 2024, grew to USD 2.80 billion in 2025 and is predicted to surpass around USD 5.51 billion by 2034, representing a healthy CAGR of 7.80% between 2024 and 2034. The North America mammography market size is calculated at USD 1.12 billion in 2024 and is expected to grow at a fastest CAGR of 7.90% during the forecast year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Mammography Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Mammography Market, by Product, 2024-2034
8.1.1. Film Screen Systems
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Digital Systems
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Analog Systems
8.1.3.1. Market Revenue and Forecast (2021-2034)
8.1.4. Biopsy Systems
8.1.4.1. Market Revenue and Forecast (2021-2034)
8.1.5. 3D Systems
8.1.5.1. Market Revenue and Forecast (2021-2034)
8.1.6. Others
8.1.6.1. Market Revenue and Forecast (2021-2034)
9.1. Mammography Market, by Technology e, 2024-2034
9.1.1. Breast Tomosynthesis Mammography
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. CAD Mammography
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Digital Mammography
9.1.3.1. Market Revenue and Forecast (2021-2034)
10.1. Mammography Market, by Modality, 2024-2034
10.1.1. Portable
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Non-Portable
10.1.2.1. Market Revenue and Forecast (2021-2034)
11.1. Mammography Market, by End Use, 2024-2034
11.1.1. Hospitals
11.1.1.1. Market Revenue and Forecast (2021-2034)
11.1.2. Special Clinics
11.1.2.1. Market Revenue and Forecast (2021-2034)
11.1.3. Diagnosis Centers
11.1.3.1. Market Revenue and Forecast (2021-2034)
11.1.4. Ambulatory Surgical Centers
11.1.4.1. Market Revenue and Forecast (2021-2034)
11.1.5. Educational & Research Institutes
11.1.5.1. Market Revenue and Forecast (2021-2034)
12.1. North America
12.1.1. Market Revenue and Forecast, by Product (2021-2034)
12.1.2. Market Revenue and Forecast, by Technology (2021-2034)
12.1.3. Market Revenue and Forecast, by Modality (2021-2034)
12.1.4. Market Revenue and Forecast, by End Use (2021-2034)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Product (2021-2034)
12.1.5.2. Market Revenue and Forecast, by Technology (2021-2034)
12.1.5.3. Market Revenue and Forecast, by Modality (2021-2034)
12.1.5.4. Market Revenue and Forecast, by End Use (2021-2034)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Product (2021-2034)
12.1.6.2. Market Revenue and Forecast, by Technology (2021-2034)
12.1.6.3. Market Revenue and Forecast, by Modality (2021-2034)
12.1.6.4. Market Revenue and Forecast, by End Use (2021-2034)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Product (2021-2034)
12.2.2. Market Revenue and Forecast, by Technology (2021-2034)
12.2.3. Market Revenue and Forecast, by Modality (2021-2034)
12.2.4. Market Revenue and Forecast, by End Use (2021-2034)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Product (2021-2034)
12.2.5.2. Market Revenue and Forecast, by Technology (2021-2034)
12.2.5.3. Market Revenue and Forecast, by Modality (2021-2034)
12.2.5.4. Market Revenue and Forecast, by End Use (2021-2034)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Product (2021-2034)
12.2.6.2. Market Revenue and Forecast, by Technology (2021-2034)
12.2.6.3. Market Revenue and Forecast, by Modality (2021-2034)
12.2.6.4. Market Revenue and Forecast, by End Use (2021-2034)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Product (2021-2034)
12.2.7.2. Market Revenue and Forecast, by Technology (2021-2034)
12.2.7.3. Market Revenue and Forecast, by Modality (2021-2034)
12.2.7.4. Market Revenue and Forecast, by End Use (2021-2034)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Product (2021-2034)
12.2.8.2. Market Revenue and Forecast, by Technology (2021-2034)
12.2.8.3. Market Revenue and Forecast, by Modality (2021-2034)
12.2.8.4. Market Revenue and Forecast, by End Use (2021-2034)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Product (2021-2034)
12.3.2. Market Revenue and Forecast, by Technology (2021-2034)
12.3.3. Market Revenue and Forecast, by Modality (2021-2034)
12.3.4. Market Revenue and Forecast, by End Use (2021-2034)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Product (2021-2034)
12.3.5.2. Market Revenue and Forecast, by Technology (2021-2034)
12.3.5.3. Market Revenue and Forecast, by Modality (2021-2034)
12.3.5.4. Market Revenue and Forecast, by End Use (2021-2034)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Product (2021-2034)
12.3.6.2. Market Revenue and Forecast, by Technology (2021-2034)
12.3.6.3. Market Revenue and Forecast, by Modality (2021-2034)
12.3.6.4. Market Revenue and Forecast, by End Use (2021-2034)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Product (2021-2034)
12.3.7.2. Market Revenue and Forecast, by Technology (2021-2034)
12.3.7.3. Market Revenue and Forecast, by Modality (2021-2034)
12.3.7.4. Market Revenue and Forecast, by End Use (2021-2034)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Product (2021-2034)
12.3.8.2. Market Revenue and Forecast, by Technology (2021-2034)
12.3.8.3. Market Revenue and Forecast, by Modality (2021-2034)
12.3.8.4. Market Revenue and Forecast, by End Use (2021-2034)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Product (2021-2034)
12.4.2. Market Revenue and Forecast, by Technology (2021-2034)
12.4.3. Market Revenue and Forecast, by Modality (2021-2034)
12.4.4. Market Revenue and Forecast, by End Use (2021-2034)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Product (2021-2034)
12.4.5.2. Market Revenue and Forecast, by Technology (2021-2034)
12.4.5.3. Market Revenue and Forecast, by Modality (2021-2034)
12.4.5.4. Market Revenue and Forecast, by End Use (2021-2034)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Product (2021-2034)
12.4.6.2. Market Revenue and Forecast, by Technology (2021-2034)
12.4.6.3. Market Revenue and Forecast, by Modality (2021-2034)
12.4.6.4. Market Revenue and Forecast, by End Use (2021-2034)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Product (2021-2034)
12.4.7.2. Market Revenue and Forecast, by Technology (2021-2034)
12.4.7.3. Market Revenue and Forecast, by Modality (2021-2034)
12.4.7.4. Market Revenue and Forecast, by End Use (2021-2034)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Product (2021-2034)
12.4.8.2. Market Revenue and Forecast, by Technology (2021-2034)
12.4.8.3. Market Revenue and Forecast, by Modality (2021-2034)
12.4.8.4. Market Revenue and Forecast, by End Use (2021-2034)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Product (2021-2034)
12.5.2. Market Revenue and Forecast, by Technology (2021-2034)
12.5.3. Market Revenue and Forecast, by Modality (2021-2034)
12.5.4. Market Revenue and Forecast, by End Use (2021-2034)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Product (2021-2034)
12.5.5.2. Market Revenue and Forecast, by Technology (2021-2034)
12.5.5.3. Market Revenue and Forecast, by Modality (2021-2034)
12.5.5.4. Market Revenue and Forecast, by End Use (2021-2034)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Product (2021-2034)
12.5.6.2. Market Revenue and Forecast, by Technology (2021-2034)
12.5.6.3. Market Revenue and Forecast, by Modality (2021-2034)
12.5.6.4. Market Revenue and Forecast, by End Use (2021-2034)
13.1. Hologic
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Fujifilm
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Siemens Healthcare
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Phillips Healthcare
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Toshiba Medical Systems
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. GE Healthcare
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Metaltronica
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. I.M.S. Srl
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Koninklijke Philips NV
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Gamma Medica, Inc
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample